Literature DB >> 647155

Tolmesoxide, a drug that lowers blood pressure by a direct relaxant effect on vascular smooth muscle.

J C Doxey.   

Abstract

1 The blood pressure of conscious, deoxycorticosterone acetate (DOCA) hypertensive and 1 kidney Goldblatt hypertensive rats and renal hypertensive and normotensive cats was reduced by tolmesoxide (4,5-dimethoxy-o-tolyl methyl sulphoxide). 2 Tachycardia accompanied the hypotension. In rats the increase in heart rate was abolished by concurrent administration of propranolol. Tachycardia did not occur in pithed rats. 3 Vascoconstriction induced by sympathetic stimulation, noradrenaline, tyramine, angiotensin or vasporessin was antagonized by tolmesoxide. 4 The antagonism of vasoconstrictor responses produced by tolmesoxide was unaffected by beta-adrenoceptor, muscarinic or histamine antagonists. 5 It is concluded that the lowering of pressure produced by tolmesoxide results from a defect relaxant effect on vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647155      PMCID: PMC1668277          DOI: 10.1111/j.1476-5381.1978.tb07780.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors.

Authors:  J C Doxey; C F Smith; J M Walker
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

2.  Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].

Authors:  D Cambridge; M J Davey; R Massingham
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

3.  STUDIES ON THE RENAL PHARMACOLOGY OF DIAZOXIDE, AN ANTIDIURETIC BENZOTHIADIAZINE.

Authors:  R M TAYLOR; A A RUBIN
Journal:  J Pharmacol Exp Ther       Date:  1964-05       Impact factor: 4.030

4.  THE EFFECT OF SYMPATHETIC NERVE STIMULATION OF VASOCONSTRICTOR RESPONSES IN PERFUSED MESENTERIC BLOOD VESSELS OF THE RAT.

Authors:  D D MCGREGOR
Journal:  J Physiol       Date:  1965-03       Impact factor: 5.182

5.  Routine direct measurement of arterial pressure in unanesthetized rats.

Authors:  J R WEEKS; J A JONES
Journal:  Proc Soc Exp Biol Med       Date:  1960 Aug-Sep

6.  The biology of meta-corticoid hypertension.

Authors:  F M STURTEVANT
Journal:  Ann Intern Med       Date:  1958-12       Impact factor: 25.391

7.  Pharmacology of diazoxide, an antihypertensive, nondiuretic benzothiadiazine.

Authors:  A A RUBIN; F E ROTH; R M TAYLOR; H ROSENKILDE
Journal:  J Pharmacol Exp Ther       Date:  1962-06       Impact factor: 4.030

8.  A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat.

Authors:  J S Gillespie; T C Muir
Journal:  Br J Pharmacol Chemother       Date:  1967-05

9.  Hypotensive and vasodilator actions of SK&F 24260, a new dihydropyridine derivative.

Authors:  R Fielden; D A Owen; E M Taylor
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

10.  The cardiovascular effects of intraventricular clonidine and Bay 1470 in conscious hypertensive cats.

Authors:  L Finch
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

View more
  7 in total

1.  Pharmacokinetics of intravenous and oral tolmesoxide.

Authors:  J G Lloyd-Jones; R Henson; J D Nichols; D Greenslade; J M Clifford
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

2.  Comparative studies on the effects of tolmesoxide (Rx71107), a tolmesoxide metabolite (Rx71112) and nifedipine in isolated blood vessels.

Authors:  E Mikkelsen; O L Pedersen
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

3.  Clinical pharmacology of tolmesoxide in refractory heart failure.

Authors:  C P O'Boyle; K McGarry; D Fitzgerald; J G Kelly; J Horgan; K O'Malley
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  The haemodynamic and metabolic effects of tolmesoxide with special reference to impaired myocardial function.

Authors:  J E Mackenzie; R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

5.  The effect of food on the pharmacokinetics and pharmacodynamics of tolmesoxide in essential hypertensives.

Authors:  H L Elliott; P A Meredith; K McLean; M A Hughes; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  A clinical and pharmacokinetic evaluation of tolmesoxide in hypertensive patients.

Authors:  J H Silas; F C Phillips; S Freestone; G T Tucker; L E Ramsay
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

7.  The clinical pharmacology of tolmesoxide. A new vasodilator antihypertensive agent.

Authors:  C P O'Boyle; M Laher; E T O'Brien; K O'Malley; J G Kelly
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.